IL37752A - Imidazo(4,5-b)pyridine-2-carbamic acid derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the same - Google Patents
Imidazo(4,5-b)pyridine-2-carbamic acid derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the sameInfo
- Publication number
- IL37752A IL37752A IL37752A IL3775271A IL37752A IL 37752 A IL37752 A IL 37752A IL 37752 A IL37752 A IL 37752A IL 3775271 A IL3775271 A IL 3775271A IL 37752 A IL37752 A IL 37752A
- Authority
- IL
- Israel
- Prior art keywords
- imidazo
- general formula
- pyridine
- preparation
- quaternary ammonium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7034133A FR2105060A1 (en) | 1970-09-21 | 1970-09-21 | Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use |
| FR7130825A FR2150236A2 (en) | 1971-08-25 | 1971-08-25 | Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL37752A0 IL37752A0 (en) | 1971-11-29 |
| IL37752A true IL37752A (en) | 1974-10-22 |
Family
ID=26215952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL37752A IL37752A (en) | 1970-09-21 | 1971-09-17 | Imidazo(4,5-b)pyridine-2-carbamic acid derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the same |
Country Status (13)
| Country | Link |
|---|---|
| AU (1) | AU453067B2 (de) |
| BE (1) | BE772835A (de) |
| CA (1) | CA940131A (de) |
| CH (1) | CH532600A (de) |
| DE (1) | DE2147103C3 (de) |
| DK (1) | DK131345B (de) |
| ES (2) | ES395260A1 (de) |
| GB (1) | GB1318859A (de) |
| HU (1) | HU163150B (de) |
| IL (1) | IL37752A (de) |
| LU (1) | LU63927A1 (de) |
| NL (1) | NL145553B (de) |
| SE (1) | SE368828B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU763431B2 (en) | 1999-03-31 | 2003-07-24 | Uaf Technologies And Research Llc | Viral treatment |
| US6593466B1 (en) | 1999-07-07 | 2003-07-15 | Isis Pharmaceuticals, Inc. | Guanidinium functionalized nucleotides and precursors thereof |
| US6384049B1 (en) | 2000-05-25 | 2002-05-07 | The Procter & Gamble Company | Cancer treatment |
-
1971
- 1971-09-17 IL IL37752A patent/IL37752A/en unknown
- 1971-09-20 BE BE772835A patent/BE772835A/xx unknown
- 1971-09-20 DK DK458771AA patent/DK131345B/da unknown
- 1971-09-20 SE SE11891/71A patent/SE368828B/xx unknown
- 1971-09-20 HU HURO628A patent/HU163150B/hu unknown
- 1971-09-20 CA CA123264A patent/CA940131A/en not_active Expired
- 1971-09-20 LU LU63927D patent/LU63927A1/xx unknown
- 1971-09-20 CH CH1372371A patent/CH532600A/fr not_active IP Right Cessation
- 1971-09-21 DE DE2147103A patent/DE2147103C3/de not_active Expired
- 1971-09-21 AU AU33735/71A patent/AU453067B2/en not_active Expired
- 1971-09-21 ES ES395260A patent/ES395260A1/es not_active Expired
- 1971-09-21 GB GB4400371A patent/GB1318859A/en not_active Expired
- 1971-09-21 NL NL717112971A patent/NL145553B/xx unknown
-
1972
- 1972-06-15 ES ES403910A patent/ES403910A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA940131A (en) | 1974-01-15 |
| ES403910A1 (es) | 1975-05-01 |
| GB1318859A (en) | 1973-05-31 |
| SE368828B (de) | 1974-07-22 |
| AU453067B2 (en) | 1974-09-19 |
| HU163150B (de) | 1973-06-28 |
| ES395260A1 (es) | 1973-12-01 |
| NL7112971A (de) | 1972-03-23 |
| NL145553B (nl) | 1975-04-15 |
| DE2147103A1 (de) | 1972-03-23 |
| DK131345C (de) | 1975-11-24 |
| AU3373571A (en) | 1973-03-29 |
| DE2147103C3 (de) | 1975-07-17 |
| DE2147103B2 (de) | 1974-11-14 |
| IL37752A0 (en) | 1971-11-29 |
| LU63927A1 (de) | 1972-06-27 |
| DK131345B (da) | 1975-06-30 |
| BE772835A (fr) | 1972-03-20 |
| CH532600A (fr) | 1973-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5260291A (en) | Tetrazine derivatives | |
| AU596400B2 (en) | Carbocyclic purine nucleosides, their production and use | |
| EP0150255B1 (de) | Immunomodulatoren auf Basis von Pyrrolo(1,2-a)imidazol und Imidazo(1,2-a)pyridin | |
| CZ301499A3 (cs) | Sloučeniny pro inhibici sekrece žaludeční kyseliny | |
| DK161147B (da) | Analogifremgangsmaade til fremstilling af oe3haa-imidazo-oe5,1-daa-1,2,3,5-tetrazin-4-onderivater | |
| EP0449726B1 (de) | Pyrimidin-Nukleosid-Derivate und antivirale Mittel, die diese Derivate als aktiven Bestandteil enthalten | |
| EP0470006B1 (de) | Thioharnstoffderivate und sie enthaltendes antimikrobielles Mittel und sie enthaltendes Mittel gegen Magengeschwüre | |
| US4234725A (en) | 4-[6-(2-Chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1-[4-(4-morpholinyl)-1-oxobutyl]-1H-pyrazole | |
| EP0237289A2 (de) | Pyrazolo[3,4-d]pyrimidinderivate, ihre Herstellung und Verwendung | |
| GB1604163A (en) | 5(6)-thio-substituted-benzimidazole-2-amines and n-alkoxycarbonyl derivatives thereof and precursors therefor all having physiological activity | |
| EP0171739B1 (de) | Imidazo[1,5-a]pyrimidinderivate und Verfahren zu ihrer Herstellung | |
| US3759938A (en) | Thiazolidine derivatives | |
| SU1487813A3 (ru) | Способ получения пенемовых соединений | |
| IL37752A (en) | Imidazo(4,5-b)pyridine-2-carbamic acid derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the same | |
| JP2632248B2 (ja) | 抗菌活性を有する４−ヒドロキシクマリン誘導体 | |
| KR950001040B1 (ko) | 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제 | |
| US3984549A (en) | Substituted pyrido-triazines as anthelmintics | |
| US3954784A (en) | Imidazo[2,1-b]thiazole and thiazolo[3,2-a]-benzimidazole quaternary salts as hypoglycemic agents and growth promotants | |
| EP0224121A2 (de) | 7-[4-Aminopiperazinyl]- oder 7-[4-Chlorpiperazinyl]chinolinonderivate,Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
| EP0105912B1 (de) | Verbesserte melaminylthioarsenite | |
| US3801583A (en) | Derivatives of 2-mercapto-pyrido(1,2-b)-1,2,4-thiadiazolium salts | |
| US3980796A (en) | Substituted 2-alkoxycarbonylamine-5-(6)-phenylmercapto-benzimidazoles | |
| EP0041322A1 (de) | m-Pyrazolylamidotetramisol-Derivate, Verfahren zur Herstellung dieser Verbindungen, sie enthaltende Zusammensetzungen sowie ihre Verwendung bei der Behandlung der Helminthiasis | |
| EP0371730A1 (de) | Dopamin-beta-hydroxylase-Hemmer | |
| IE48355B1 (en) | Imidazo(1,2-a)imidazole derivatives |